- Impact and Challenges of the COVID-19 Pandemic on Patients Requiring Botulinum Toxin A Treatment
-
Pajo AT, Espiritu AI, Jamora RDG
- KMID: 2511485
- J Mov Disord.
- 2021 Jan;14(1):29-33.
- doi: 10.14802/jmd.20088
-
- CITED
-
- Close
- SHARE
-
- Close
- Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
-
Fernando EZ, Yu JRT, Santos SMA, Jamora RDG
- KMID: 2511492
- J Mov Disord.
- 2021 Jan;14(1):75-77.
- doi: 10.14802/jmd.20091
Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of... -
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 Vaccine-Related Movement Disorders: A Systematic Review
-
Angeles GED, Dichoso LPC, Jamora RDG
- KMID: 2558077
- J Mov Disord.
- 2024 Jul;17(3):322-327.
- doi: 10.14802/jmd.24001
Objective Since the release of vaccines against coronavirus disease 2019 (COVID-19), there have been reports of vaccine-related neurologic complications. This study aimed to perform a descriptive systematic review of movement... -
- CITED
-
- Close
- SHARE
-
- Close
